Ryanodine receptor antagonist blocked ischemic tolerance, while a ryanodine receptor agonist stimulated the production of ischemic tolerance.
Ryanodine receptor antagonists prevented short-term oxygen/glucose deprivation induced preconditioning.
Ryanodine receptor protein and also mRNA levels decreased after induction of ischemic tolerance.